Cyclacel changes control; new majority owner holds 70% and appoints new CEO and CFO

Bio Green Med Solution, Inc.

Datuk Dr. Doris Wong Sing Ee bought 1M Series C and 1.745M Series D shares from ex-interim CEO David Lazar for $6.3M, gaining 70% ownership.
Preferred shares converted into 194.63M common shares, making Wong the controlling shareholder.
David Lazar resigned as interim CEO; Datuk Dr. Doris Wong Sing Ee appointed CEO and director; Kiu Cu Seng appointed CFO, executive director, secretary.
Five directors resigned, including Samuel Barker, Paul McBarron, Spiro Rombotis; new independent director Chong Kwang Fock appointed.
Nasdaq compliance regained for equity rule; company subject to one-year Mandatory Panel Monitor.

item 1.01 item 5.02 item 3.01 item 3.03 item 5.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change (interim)

David Lazar

Interim Chief Executive Officer

BGMS · Bio Green Med Solution, Inc.

Effective: 2025-02-26
Successor: Datuk Dr. Doris Wong Sing Ee
Filed: February 27, 2025, 6:59 PM ET

David Lazar, the Company’s interim Chief Executive Officer, interim principal financial officer, interim principal accounting officer, and Secretary, provided notice of his resignation as Chief Executive Officer and Secretary of the Company effective February 26, 2025.

Appointed

Datuk Dr. Doris Wong Sing Ee

Director

BGMS · Bio Green Med Solution, Inc.

Effective: 2025-02-26
Filed: February 27, 2025, 6:59 PM ET

Datuk Dr. Doris Wong Sing Ee was also elected to the Board of the Company as of the effective date.

Appointed

Datuk Dr. Doris Wong Sing Ee

Chief Executive Officer

BGMS · Bio Green Med Solution, Inc.

Effective: 2025-02-26
Filed: February 27, 2025, 6:59 PM ET

the Board appointed Datuk Dr. Doris Wong Sing Ee, as Chief Executive Officer and, in such role, she will serve as the Company’s principal executive officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Lazar resigned as Interim Chief Executive Officer at Bio Green Med Solution, Inc..

Action: resigned
Role: Interim Chief Executive Officer

Exact text from the filing

David Lazar, the Company’s interim Chief Executive Officer, interim principal financial officer, interim principal accounting officer, and Secretary, provided notice of his resignation as Chief Executive Officer and Secretary of the Company effective February 26, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Datuk Dr. Doris Wong Sing Ee was elected as Director at Bio Green Med Solution, Inc..

Action: elected
Role: Director

Exact text from the filing

Datuk Dr. Doris Wong Sing Ee was also elected to the Board of the Company as of the effective date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Datuk Dr. Doris Wong Sing Ee was appointed as Chief Executive Officer at Bio Green Med Solution, Inc..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

the Board appointed Datuk Dr. Doris Wong Sing Ee, as Chief Executive Officer and, in such role, she will serve as the Company’s principal executive officer.

View on SEC.gov

Bio Green Med Solution, Inc. filing history →

Source: SEC EDGAR

accession 0001829126-25-001253

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.